PanGIA Biotech announced today four of its abstracts were accepted for presentation at the 7th Annual Congress of Liquid ...

Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B virus AB-101 clinical data abstract recognized as a ...

Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin ...

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ...

Materna Medical announces oral presentation of an abstract titled "An Interim Sub-Analysis of Nulliparous Subjects in the POMPOM Study Evaluating the Efficacy of the Milli Expanding Dilator as a ...

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology’s (ACR) annual meeting, ACR ...

Remember Clippy? Microsoft's infamous paper clip assistant might have been before its time. The software giant has introduced ...

Information regarding ASN's Kidney Week, including copies of presentation abstracts, can be found here. In addition to the poster presentations during ASN’s Kidney Week, Ardelyx is sponsoring an ...

Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with ...